hydromorphone hydrochloride injection, USP (HIGH POTENCY) How Supplied/Storage and Handling

()

16 HOW SUPPLIED/STORAGE AND HANDLING

Hydromorphone Hydrochloride Injection, USP (HPF) is supplied in single-dose amber vials. Each single-dose vial of sterile aqueous solution contains 10 mg per mL of hydromorphone hydrochloride, USP with 0.2% sodium citrate and 0.2% citric acid solution. Hydromorphone Hydrochloride Injection, USP (HPF) is preservative free and is supplied as follows:

Unit of SaleConcentration
*
DILUTE PRIOR TO USE. FOR USE IN THE PREPARATION OF LARGE VOLUME PARENTERAL SOLUTIONS.
NDC 0409-2634-01
Box containing 10 Single-dose vials (1 mL)
10 mg/mL
NDC 0409-2634-05
Box containing 10 Single-dose vials* (5 mL)
50 mg/5 mL (10 mg/mL)
NDC 0409-2634-50
Box containing 1 Single-dose vial* (50 mL)
500 mg/50 mL (10 mg/mL)

No added preservative.

PROTECT FROM LIGHT.

Keep covered in carton until time of use. Store at 20° to 25°C (68° to 77°F); [see USP Controlled Room Temperature].

Safety and Handling Instructions

Access to drugs with a potential for abuse such as Hydromorphone Hydrochloride Injection, USP [high potency formulation (HPF)] presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by healthcare providers.

Find hydromorphone hydrochloride injection, USP (HIGH POTENCY) medical information:

Find hydromorphone hydrochloride injection, USP (HIGH POTENCY) medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

hydromorphone hydrochloride injection, USP (HIGH POTENCY) Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

Hydromorphone Hydrochloride Injection, USP (HPF) is supplied in single-dose amber vials. Each single-dose vial of sterile aqueous solution contains 10 mg per mL of hydromorphone hydrochloride, USP with 0.2% sodium citrate and 0.2% citric acid solution. Hydromorphone Hydrochloride Injection, USP (HPF) is preservative free and is supplied as follows:

Unit of SaleConcentration
*
DILUTE PRIOR TO USE. FOR USE IN THE PREPARATION OF LARGE VOLUME PARENTERAL SOLUTIONS.
NDC 0409-2634-01
Box containing 10 Single-dose vials (1 mL)
10 mg/mL
NDC 0409-2634-05
Box containing 10 Single-dose vials* (5 mL)
50 mg/5 mL (10 mg/mL)
NDC 0409-2634-50
Box containing 1 Single-dose vial* (50 mL)
500 mg/50 mL (10 mg/mL)

No added preservative.

PROTECT FROM LIGHT.

Keep covered in carton until time of use. Store at 20° to 25°C (68° to 77°F); [see USP Controlled Room Temperature].

Safety and Handling Instructions

Access to drugs with a potential for abuse such as Hydromorphone Hydrochloride Injection, USP [high potency formulation (HPF)] presents an occupational hazard for addiction in the health care industry. Routine procedures for handling controlled substances developed to protect the public may not be adequate to protect health care workers. Implementation of more effective accounting procedures and measures to restrict access to drugs of this class (appropriate to the practice setting) may minimize the risk of self-administration by healthcare providers.

Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.